HK48597A - Inhibition of allograft and concordant xenograft rejection - Google Patents

Inhibition of allograft and concordant xenograft rejection Download PDF

Info

Publication number
HK48597A
HK48597A HK48597A HK48597A HK48597A HK 48597 A HK48597 A HK 48597A HK 48597 A HK48597 A HK 48597A HK 48597 A HK48597 A HK 48597A HK 48597 A HK48597 A HK 48597A
Authority
HK
Hong Kong
Prior art keywords
cyclosporin
rejection
immunosuppressant
survival
allograft
Prior art date
Application number
HK48597A
Other languages
German (de)
English (en)
French (fr)
Inventor
James Graham White David
Beyers Van Den Bogaerde Johan
Original Assignee
Imutran Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imutran Limited filed Critical Imutran Limited
Publication of HK48597A publication Critical patent/HK48597A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
HK48597A 1990-04-09 1997-04-17 Inhibition of allograft and concordant xenograft rejection HK48597A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909007971A GB9007971D0 (en) 1990-04-09 1990-04-09 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
HK48597A true HK48597A (en) 1997-04-25

Family

ID=10674123

Family Applications (1)

Application Number Title Priority Date Filing Date
HK48597A HK48597A (en) 1990-04-09 1997-04-17 Inhibition of allograft and concordant xenograft rejection

Country Status (22)

Country Link
EP (1) EP0527762B1 (enExample)
JP (1) JP3518547B2 (enExample)
CN (1) CN1040178C (enExample)
AT (1) ATE141167T1 (enExample)
AU (1) AU7555591A (enExample)
CZ (1) CZ283119B6 (enExample)
DE (1) DE69121401T2 (enExample)
DK (1) DK0527762T3 (enExample)
ES (1) ES2090325T3 (enExample)
GB (1) GB9007971D0 (enExample)
GR (1) GR3021642T3 (enExample)
HK (1) HK48597A (enExample)
IE (1) IE911153A1 (enExample)
IL (1) IL97788A (enExample)
IN (1) IN173149B (enExample)
MY (1) MY106158A (enExample)
NZ (1) NZ237739A (enExample)
PT (1) PT97277B (enExample)
SG (1) SG47465A1 (enExample)
SK (1) SK279949B6 (enExample)
WO (1) WO1991015221A1 (enExample)
ZA (1) ZA912467B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE297217T1 (de) 1999-10-27 2005-06-15 Alexandra Lucas Zusammensetzung zur vorbeugung und behandlung von transplantatabstossung
US7419670B2 (en) 2000-09-29 2008-09-02 Viron Therapeutics, Inc. Method of treating arthritis with SERP-1 and an immunosuppressant
EP2338511A3 (en) * 2004-05-14 2012-07-25 Alexion Pharmaceuticals, Inc. Prolongation of survival of an allograft by inhibiting complement activity
US7285530B2 (en) 2004-10-21 2007-10-23 Viron Therapeutics, Inc. Use of SERP-1 as an antiplatelet agent
LT3028716T (lt) 2006-10-10 2020-12-10 Regenesance B.V. Komplemento slopinimas nervų regeneracijos pagerinimui
JP6223659B2 (ja) 2008-11-10 2017-11-01 アレクシオン ファーマシューティカルズ， インコーポレイテッド 補体関連障害を処置するための方法および組成物
AU2014306002B2 (en) 2013-08-07 2017-05-25 Alexion Pharmaceuticals, Inc. Atypical hemolytic uremic syndrome (aHUS) biomarker proteins
WO2026064591A1 (en) * 2024-09-20 2026-03-26 Antinous Technology Company Limited Methods and compositions for preventing herpes virus reactivation in organ xenograft

Also Published As

Publication number Publication date
IL97788A (en) 1998-02-08
JPH05507266A (ja) 1993-10-21
IE911153A1 (en) 1991-10-09
DK0527762T3 (da) 1996-09-02
CN1056240A (zh) 1991-11-20
GR3021642T3 (en) 1997-02-28
SG47465A1 (en) 1998-04-17
IN173149B (enExample) 1994-02-19
GB9007971D0 (en) 1990-06-06
EP0527762A1 (en) 1993-02-24
PT97277B (pt) 1998-08-31
AU7555591A (en) 1991-10-30
MY106158A (en) 1995-03-31
ZA912467B (en) 1992-12-30
CN1040178C (zh) 1998-10-14
EP0527762B1 (en) 1996-08-14
IL97788A0 (en) 1992-06-21
WO1991015221A1 (en) 1991-10-17
ATE141167T1 (de) 1996-08-15
JP3518547B2 (ja) 2004-04-12
CZ283119B6 (cs) 1998-01-14
NZ237739A (en) 1993-09-27
DE69121401T2 (de) 1996-12-12
ES2090325T3 (es) 1996-10-16
SK279949B6 (sk) 1999-06-11
CS9100988A2 (en) 1991-12-17
PT97277A (pt) 1992-01-31
DE69121401D1 (de) 1996-09-19

Similar Documents

Publication Publication Date Title
CRAMER et al. Cardiac transplantation in the rat: II. Alteration of the severity of donor graft arteriosclerosis by modulation of the host immune response
EP0631784B1 (en) Sulphated polysaccharides having anti-inflammatory activity
KR20040101381A (ko) 신규한 용도
HK1222342A1 (en) Prolongation of survival of an allograft by inhibiting complement activity
US8435520B2 (en) Combinations of immunosuppressive agents for the treatment or prevention of graft rejections
EP0527762B1 (en) Inhibition of allograft and concordant xenograft rejection
RU2014837C1 (ru) Средство для лечения панкреатита и предупреждения отторжения трансплантата поджелудочной железы и способ предупреждения отторжения трансплантата поджелудочной железы
US20010018051A1 (en) Inhibition of allograft and concordant xenograft rejection
Clasen et al. Long-term treatment of minimal-change nephrotic syndrome with cyclosporin: a control biopsy study
Hall et al. Treatment of renal transplantation rejection Cyclosporin A versus conventional treatment with azathioprine, prednisone and antithymocyte immunoglobulin in primary cadaveric renal transplantation
JPS6272621A (ja) コレラ毒素類を活性成分とする免疫抑制剤
Kahn et al. Use of verapamil with conventional immunosuppression after porcine renal transplantation
de Bruin et al. Small bowel transplantation in rats: the effect of pretransplant donor-specific blood transfusions on various segments of small bowel grafts
DeKlerk et al. New Methods of Treatment for Renal Allotransplant Using the Baboon as a Primate Experimental Model
US6503948B2 (en) Method for prevention or treatment of acute allograft rejection and a pharmaceutical composition therefor
de Bruin et al. The effect of pretransplant donor-specific blood transfusions on various segments of small bowel grafts
Takiff et al. Low-dose cyclosporine maintenance therapy after immunosuppressive induction in a rat cardiac transplant model
Thomson et al. Rejection, the Immune Response, and the Influence of Cyclosporin A
Sobh et al. Cyclosporine in the treatment of steroid resistant rejection episodes in living donor kidney transplants
Bass The Eosinophil leucocyte: a cell in search of a role
HK1014153B (en) Sulphated polysaccharides having anti-inflammatory activity

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20080404